ReviewThe International journal of angiology : official publication of the International College of Angiology, Inc2025
Spontaneous Coronary Artery Dissection Clinical Review: Current State of Evidence and Challenges Ahead.
Review in The International journal of angiology : official publication of the International College of Angiology, Inc, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spontaneous coronary artery dissection (SCAD) has been increasingly recognized as a potentially serious nonatherosclerotic condition that can mimic atherosclerotic acute coronary syndromes. This condition has been identified as presenting with the classical clinical and electrocardiographic features that are encountered with acute coronary syndromes. Its formal identification has been historically challenging and difficult. A high index of clinical suspicion before invasive coronary angiography depends on the presence of some inherited and acquired risk factors. Early suspicion plays a key role in the identification of SCAD lesions during coronary angiography. Multiple angiographic features may be present, thus resulting in different types of SCAD lesions. Acute SCAD management favors conservative approaches for stable cases, with revascularization for high-risk presentations. Pharmacotherapy typically includes antiplatelet agents and β-blockers, avoiding routine anticoagulation. Long-term care involves recurrence prevention, monitoring, counseling, and screening for extra coronary fibromuscular dysplasia. Significant areas of uncertainty remain, as this relates to the best long-term management and surveillance strategies. This review aims to summarize the current state of knowledge and evidence, while pointing out the remaining challenges and the need for additional research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.